Hepatitis C
The true cost of viral hepatitis is not measured in the cost of one drug. It is how this epidemic will continue to grow if policymakers do nothing - Mazie Hirono

image by: HWN
HWN Suggests
Why Egypt Is at the Forefront of Hepatitis C Treatment
Just five years ago, with the best medical therapies available, the odds of curing a person infected with hepatitis C were no better than a coin toss. Eliminating the disease from a whole country was unthinkable.
But today, Egypt is wiping the disease from its population at an unprecedented pace. The effort was made possible by revolutionary new drugs—but no country, including the United States, has come close to deploying them at equivalent scale. Egypt has shown that dramatic improvements in public health are possible when drugs are priced affordably—and a government makes an effort to systematically deploy them. But Egypt is also the exception that proves the rule that while modern…
Featured
Baby Boomers Have High Incidence Of Hepatitis C Virus: What Does This Mean, Boomer?
Approximately one in thirty individuals born from 1945-1965 screen positive for Hepatitis C. Another way of looking at it shows that over 75% of those with Hepatatis C are baby boomers. Routine screening of blood products used for transfusion to eliminate transmission of Hepatitis C began in 1992.
The Battle to Get Expensive Hep C Treatment in Prisons
The disease is common in prison populations but states face a catch-22: spend their entire medical budgets on newer drugs or use cheaper treatments that are less effective.
The VA Will Eliminate Hepatitis C In Veterans By Year-End
This is a great story. Thanks to the VA’s commitment as well as the innovation on the part the manufacturers, a major health issue for our veterans will be eliminated.
We’re on track to eliminate hepatitis C, but stigma remains and reinfection is a risk
The world is watching as Australia tries to be one of the first countries in the world to eliminate hepatitis C. The final national hepatitis C health strategy is expected to be released before the end of 2023. But the number of people coming forward for treatment has dropped significantly. Resources are being marshalled into finding people, and keeping the momentum going on elimination.
Articles of Interest
Viral Hepatitis National Strategic Plan: 2021–2025
The Hepatitis Plan provides goal-oriented objectives and strategies that can be implemented by a broad mix of stakeholders at all levels and across many sectors, both public and private.
Harvoni Takes the Sting Out of Hepatitis C Treatment
For the first time, hepatitis C can be cured without interferon and ribavirin, which can cause fatigue and depression.
Hepatitis C Medications
The goal of HCV treatment is to cure the virus, which can be done with a combination of drugs. The specific meds used and the duration of treatment depend on a number of factors, including HCV genotype (genetic structure of the virus), viral load, past treatment experience, degree of liver damage, ability to tolerate the prescribed treatment, and whether the person is waiting for a liver transplant or is a transplant recipient. In some cases, HCV treatment may be limited by your health insurance plan or drug formulary.
Information for Healthcare Personnel Potentially Exposed to Hepatitis C Virus (HCV)
After a needlestick or sharps exposure to HCV-positive blood, the risk of HCV infection is approximately 1.8%2 . If the healthcare worker does become infected, follow AASLD/IDSA guidelines (www.hcvguidelines.org) for management and treatment of hepatitis C.
The hepatitis C virus was discovered in 1989 – research that’s now earned a Nobel Prize. BSIP/Universal Images Group via Getty Images A researcher reflects on progress fighting hepatitis C – and a path forward
When I began my medical career in Hong Kong in the early 1980s, I chose to focus on hepatitis B, in part because it was very common and because the hepatitis C virus had not yet been discovered. I witnessed the devastation that this virus caused – cirrhosis, liver failure and liver cancer – and the lack of treatments we could offer to patients. Back then, scientists knew there was another type of hepatitis, but no one could identify it, so we called it non-A, non-B hepatitis. I would never have imagined that during the course of my career I would witness the discovery of what came to be known as hep C and the development of a cure for nearly all patients with chronic hepatitis C in 2014.
Treat all with hepatitis C, World Health Organization recommends
The World Health Organization says that the safety and effectiveness of newer direct-acting antivirals (DAAs) have shifted the balance of risks and benefits towards recommending treatment for all. Furthermore, growing access to lower-cost DAAs is enabling treatment to be rolled out rapidly in some low- and middle-income countries.
Treatment Options in Hepatitis C
All patients with hepatitis C, whatever their disease stage, can derive a sustained eradication of HCV from a combination of drugs with direct antiviral activity. Viral eradication is associated with a better quality of life and with lower morbidity and mortality.
We Now Have the Cure for Hepatitis C, but Can We Afford It?
A long, difficult and costly research effort gives doctors a new cure for hepatitis C.
Are New Drugs for Hepatitis C Safe? A Report Raises Concerns
Drugs approved in recent years that can cure hepatitis C may have severe side effects, including liver failure, a new report suggests. The number of adverse events appears relatively small, and the findings are not conclusive. But experts said the report was a warning that should not be ignored. It involves nine widely used antiviral drugs that were heralded as a huge advance because they greatly increased cure rates, seemingly with few side effects.
Baby boomers and hepatitis C: What’s the connection?
Why is the prevalence of HCV so high among baby boomers? Risk factor assessments suggest that this group may have been more likely to engage in occasional or ongoing injection drug use during young adulthood, particularly in the 1970s and 1980s.
Curing Hepatitis C, in an Experiment the Size of Egypt
Six million Egyptians were infected with hepatitis C by unsterile needles during the country’s decades-long fight against schistosomiasis. The virus spread insidiously; today, at least 10 percent of Egyptians, nearly nine million people, are chronically infected, the highest rate in the world.
FDA Warns on Hepatitis C Drugs
The agency is requiring black-box warnings for nine antiviral drugs that can reactivate hepatitis B.
From Retirement To The Front Lines Of Hepatitis C Treatment
When a hepatitis C treatment called Harvoni was released in 2014, Dr. Ronald Cirillo knew it was big. "It's the reason that dragged me out of retirement!" he says.
Global health experts say elimination of hepatitis C in the US is possible: How do we make it happen?
With a growing consensus in the global health community that Hepatitis C (HCV) could be eliminated, a new report highlights a key missing element needed to achieving complete elimination — adequate surveillance and monitoring — and explains how modest investments would improve lives and save money.
Hepatitis Country: Inside America's Hep C Epidemic
According to the Centers for Disease Control and Prevention (CDC), an estimated 3.5 million people in the United States are living with chronic hepatitis C infection, and most are unaware that they are infected.
I Got Hepatitis C and Lost My Friends
It felt as if I had been propelled onto another planet, a desolate place with no landmarks.
More Prison Inmates Get Access to Hepatitis-C Drugs
Public-health experts say inmates have a higher hepatitis C-infection rate than the general population because many have a history of drug injection, a common route of transmission for the blood-borne virus. The infection can damage the liver and become life-threatening if left untreated.
Most Adults Should be Screened for Hepatitis C, New U.S. Guidelines Urge
The opioid crisis and an increase in illicit drug use have fueled a resurgence of hepatitis C, a viral infection of the liver.
New Hepatitis C Drug Gets Helping Hand
The largest manager of U.S. prescription-drug benefits is taking sides in a fight between new hepatitis C treatments that cost close to $100,000 per patient. Express Scripts Holding Co. will make an AbbVie Inc. drug the exclusive option for patients with the most common form of hepatitis C. The move will help the drug maker take market share from Gilead Sciences Inc., which makes the blockbuster Sovaldi, but is likely to be controversial for limiting doctors’ and patients’ treatment choices.
Resolved For 2015: No More Hepatitis C
I'll spell out the vows that I believe all the key stakeholders in the fight against hepatitis C should follow in the year ahead.
The Nobel in Medicine went to 3 scientists who co-discovered hepatitis C
Harvey J. Alter, Michael Houghton, and Charles M. Rice “made possible blood tests and new medicines that have saved millions of lives.”
This Disease Is A Top Killer And Now States Must Pay For Its Costly Treatment
The antiviral drugs have since become cheaper, but judicial decisions and settlements have consistently found that states cannot deny treatment because of cost in any case.
We have a cure for hepatitis C. But the neediest can’t afford it. Louisiana wants to change that
Beginning in 2014, several medications that cure hepatitis C within weeks of therapy became available, revolutionizing care for infected individuals. The catch was the price tag.
While Washington Tackles Opioid Abuse Epidemic, Hepatitis C Treatment Remains Unaffordable
If Washington wants to do something about the public health issues left behind by the opioid abuse epidemic, it might have to start doing something about prescription-drug costs.
Why Hepatitis C Still Kills 16,000 Americans Per Year, and What We Can Do About It
Many patients infected with hepatitis C have no symptoms -- the virus attacks with insidious stealth -- and thus no cause to suspect they are infected, much less take action. You can look and feel absolutely healthy, even as serious liver damage worsens. All too often, as a result, this hidden disease remains long undetected, sometimes for decades.
Resources
Is $1,125 hepatitis pill from Bay Area drugmaker worth it?
Gilead has continued to argue that a cure achieved in a few months is less expensive than the costs of the disease’s complications further down the road, such as treatments for liver cancer or liver transplants.
10 Reasons to Get a Hep C Screening
Without screening, the virus can go undetected for years, if not decades, leading to potentially serious complications, including liver cirrhosis and liver cancer. Regular screenings can help identify the disease at an early stage, increasing the likelihood of a successful treatment outcome.
Hepatitis C Online
A free educational website from the University of Washington Infectious Diseases Education & Assessment (IDEA) program.
HepCHope.com
Hepatitis C (Hep C) is a serious, blood-borne disease that has been under the radar. It’s not talked about much, so even though it affects millions, many people don’t know about it. It’s almost been forgotten.
Coalition for Global Hepatitis Elimination
The Coalition for Global Hepatitis Elimination is a nonprofit founded in 2019 as a program of The Task Force for Global Health. The Coalition pursues worldwide elimination of viral hepatitis by strengthening capacity at the local level, bringing together global partners to share knowledge, data, and experiences related to hepatitis prevention, testing, and care and treatment.
HCV Dashboard
The purpose of the HCV Dashboard is to measure, track and disseminate actionable information on progress towards eliminating hepatitis C as a public health problem in New York State.
Hep
Hep is an award-winning print and online brand for people living with and affected by viral hepatitis. Offering unparalleled editorial excellence since 2010, Hep and HepMag.com are the go-to source for educational and social support for people living with hepatitis.
Hep C Challenge
The Caring Ambassadors Program uses a unique approach in our work to address the elimination of viral hepatitis and specifically hepatitis C.
Hepatitis C Association
The focus of the Hepatitis C Association is to educate the public, both patients and medical providers, about hepatitis C virus. We offer factual information through educational programs and support materials.
Hepatitis Central
All the information you need about living with Hepatitis C, including the latest news about infection, transmission, symptoms, treatment breakthroughs and medical progress.
HepCMyWay
HepCMyWay offers PA & OH residents in-home Hepatitis C treatment to anyone who needs it. If you've tested positive for Hep C, we’ll work together virtually to develop a treatment plan and deliver medications to your front door.
I Help C
Your best friends guide to Hepatitis C and Cirrhosis.
The Hep Vine
We publish news & research related to Hepatitis prevention & treatment. On our blog you can also read stories about people who have lived with hep B & C.
Epclusa
EPCLUSA was the first Hep C therapy proven to effectively treat all six main Hep C genotypes with a simple one-pill, once-a-day treatment regimen for the majority of patients.*
InfoHep
Hepatitis C is curable. The treatment of hepatitis C has made great progress since the virus was identified in 1988.
CDC
HCV RNA appears in blood and can be detected as early as 2–3 weeks after infection.
MayoClinic
Hepatitis C is one of several hepatitis viruses and is generally considered to be among the most serious of these viruses. Hepatitis C is passed through contact with contaminated blood – most commonly through needles shared during illegal drug use.
WHO
Every year, 3—4 million people are infected with the hepatitis C virus. About 150 million people are chronically infected and at risk of developing liver cirrhosis and/or liver cancer. More than 350 000 people die from hepatitis C-related liver diseases every year.

